Non-peptide
C60
Also known as
carbon 60 · fullerene · buckminsterfullerene · buckyballs · C60-OO · C60 olive oil
Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.
What it is
| Carbon molecule in oil | A cage of 60 carbon atoms, also called fullerene or buckyballs. Longevity discussion concerns experimental oral oil preparations. |
|---|---|
| Different products | Oral C60 oil and topical fullerene cosmetics are separate uses. C60 is neither a peptide nor graphene. |
Notes
C60 is a molecule of 60 carbon atoms, discussed as an experimental oral oil for longevity and stamina. Reports include better cardio, no noticeable benefit and adverse symptoms. These do not establish slower aging.
A carbon cage carried in oil. Buckminsterfullerene, fullerene and buckyballs are names used for C60. C60-OO means C60 in olive oil; the oil carries the molecule and contributes its own calories and properties. It is not a peptide or graphene.
Different fullerene products are different experiments. Other vegetable-oil preparations appear in discussion. Topical fullerene cosmetics do not establish what swallowing C60 oil does. A bottle's color or concentration claim does not establish its composition.
What people notice
| Cardio and stamina | One long-term user describes better cardio. Another reports more activity after two weeks but repeatedly says their underlying exhaustion remains. |
|---|---|
| No noticeable benefit | Separate users report no appreciable effect across products or nothing noticeable after more than a year. |
| Sleep and focus stories | One contributor describes better sleep, vivid dreams, focus and energy while also exercising, fasting and using other supplements. These reports do not measure slower aging. |
Notes
Cardio, rather than a stimulant kick. NukeZA describes better cardio but explicitly rejects C60 as a nootropic or cure-all. Stamina and fatigue experiences differ between accounts. C60 in olive oil: differing long-use experiences (Community discussion · Accessed 2026-09-30)
More stamina can coexist with exhaustion. After two weeks, stevesayshi described longer physical and mental activity, less anxiety and more appetite. Follow-ups preserve baseline exhaustion and careful activity, not recovery. C60 in olive oil: stamina with unchanged exhaustion (Personal report · Accessed 2026-09-30)
Long use can still feel like nothing. Beef_Newton reports no appreciable benefit across multiple products over long periods. Tintinet likewise reports nothing noticeable after more than a year. These counteraccounts matter alongside enthusiastic energy stories. C60 in olive oil: differing long-use experiences (Community discussion · Accessed 2026-09-30) · C60 updates: a year-plus null report (Community discussion · Accessed 2026-09-30)
Sleep, focus and general vitality are also claimed. A Biohackers contributor reports better sleep, vivid dreams, focus and energy. The account also includes exercise, fasting and other supplements, so it cannot isolate C60's contribution. Big_Un1t79's long-use C60 story (Personal report · Accessed 2026-09-30)
Longevity remains a hope, not a felt result. NukeZA continues partly for possible longevity effects but says only time will tell. Years of use and better cardio do not measure lifespan. NukeZA's long-term C60 account (Personal report · Accessed 2026-09-30)
Source context — C60 in olive oil: differing long-use experiences: Anonymous retrospective reports, unassayed products, no blinded comparison. NukeZA also appears in the consensus thread; count as one person. Product sourcing and speculative diagnosis in replies are not adopted.
Source context — C60 in olive oil: stamina with unchanged exhaustion: One ME/CFS account, not a healthy-user or recovery trial. Same-author follow-ups narrow the headline. Concentration and exposure unverified; author's proposed mechanisms and advice not adopted.
Source context — C60 updates: a year-plus null report: Null report is one self-prepared-oil user; no concentration assay or control. Repeated quoted copies of tintinet's post are not more users. Only inspected first page, not all108 replies.
Source context — Big_Un1t79's long-use C60 story: Retrospective report with unspecified C60 amount, unverified formulation and multiple habits. Persistent benefits not lifelong particle retention. Relative timestamp only; original publication date not inferred. No supporting illness/biomarker record inspected.
Source context — NukeZA's long-term C60 account: Same person as f63qxx, self-prepared oil, no assay or objective causal test. Weekly amount is not a specified per-administration or daily dose. Manufacturing recipe and supplier not reproduced. Good bloodwork is not comprehensive safety evidence.
Doses people talk about
| 5 mg per week | One long-term oral-oil user's weekly total; the account does not specify how that total was divided. |
|---|---|
| 3 mg, five days per week | The amount in one ME/CFS stamina report. A separate person reports 7 mg daily for more than a year with nothing noticeable. |
| 5 mL per use | A training log claims 0.88 mg/mL, making 4.4 mg if accurate. Later uses reached 10 mL and included skipped days; the concentration was not checked. |
| Teaspoon to tablespoon talk | These are oil volumes, not universal C60 amounts. Brand concentration varies; the saved 25.6 mg-per-ounce example does not settle spoonful strength. |
Notes
5 mg per week in one long-term account. NukeZA reports oral C60 in olive oil since March 2015, mostly at that weekly total. It is not a stated 5 mg daily amount or a verified optimal dose. NukeZA's long-term C60 account (Personal report · Accessed 2026-09-30)
NukeZA reply: since March 2015, mostly 5 mg/week; cardio and possible alcohol-tolerance changes, no noticed side effects, good last bloodwork; replies question a separate cancer assertion. NukeZA's long-term C60 account (Personal report · Accessed 2026-09-30)
3 mg on five days per week; separately, 7 mg daily. These are different users: stevesayshi's ME/CFS report and tintinet's year-plus account with no noticeable result. Keep their frequencies and outcomes separate. C60 in olive oil: stamina with unchanged exhaustion (Personal report · Accessed 2026-09-30) · C60 updates: a year-plus null report (Community discussion · Accessed 2026-09-30)
5 mL per use at a claimed 0.88 mg/mL. Demogirl06's training log initially describes this oral oil amount, equivalent to 4.4 mg if the concentration is correct. Later entries include 10 mL uses and skipped days; the reported concentration was not independently checked. Demogirl06: a complete mixed C60 training log (Personal report · Accessed 2026-09-30)
A teaspoon or tablespoon is an oil volume. The original community record includes both spoon sizes and a commercial example of 25.6 mg per ounce. Concentration and ounce convention matter; spoon volumes cannot supply a universal C60 amount. Saturation and maintenance calculators are commercial claims, not established human requirements.
Oil spoon talk: 1 teaspoon to 1 tablespoon of C60 olive oil is the home-biohack range. Concentration varies by brand, so a teaspoon is not a milligram. [community]
Source context — NukeZA's long-term C60 account: Same person as f63qxx, self-prepared oil, no assay or objective causal test. Weekly amount is not a specified per-administration or daily dose. Manufacturing recipe and supplier not reproduced. Good bloodwork is not comprehensive safety evidence.
Source context — C60 in olive oil: stamina with unchanged exhaustion: One ME/CFS account, not a healthy-user or recovery trial. Same-author follow-ups narrow the headline. Concentration and exposure unverified; author's proposed mechanisms and advice not adopted.
Source context — C60 updates: a year-plus null report: Null report is one self-prepared-oil user; no concentration assay or control. Repeated quoted copies of tintinet's post are not more users. Only inspected first page, not all108 replies.
Source context — Demogirl06: a complete mixed C60 training log: Single evolving account with major training/sleep/injury/caffeine confounding and unverified commercial concentration. 4.4 mg is transparent multiplication of claimed0.88 mg/mL by5 mL, not an assayed dose. No rat-to-human scaling, purchase guidance or tissue-repair inference adopted.
Half-life, onset & duration
| Felt onset | Hip reports immediate mild awareness, energy and calm after 1 mL. A separate secondhand story describes improvement over days to weeks; these are different people. |
|---|---|
| Felt duration | No dependable benefit window. Hip's adverse symptom flare took about two days to clear; another user's claim of benefits two years after stopping does not measure clearance. |
| Half-life | No measured human oral-oil value is established here. Forum estimates of one or two days use a different fullerene or personal guesses; rat measurements are separate context. |
Notes
Immediate mild effects in one 1 mL account. Hip describes increased awareness, energy and calm after oral C60 oil, followed by an adverse next day. Hip's one-dose experience and a separate anonymous improvement story (Community discussion · Accessed 2026-09-30)
Days to weeks in a secondhand improvement story. The same thread relays another person's improvement after starting 1 mL daily, reported as 0.8 mg C60. That anonymous story is distinct from Hip's own one-dose experience and does not establish a usual onset. Hip's one-dose experience and a separate anonymous improvement story (Community discussion · Accessed 2026-09-30)
About two days for one reported symptom flare to clear. Hip describes post-exertional malaise, meaning a worsening of illness symptoms, despite little exertion. This is an adverse-event timeline, not a beneficial-effect window or proof of bodily clearance. Hip's one-dose experience and a separate anonymous improvement story (Community discussion · Accessed 2026-09-30)
A two-year persistence claim is retrospective. The Biohackers contributor says benefits continued two years after stopping. This does not prove lifelong C60 retention or a reproducible one-dose duration. Big_Un1t79's long-use C60 story (Personal report · Accessed 2026-09-30)
No measured human oral half-life in these accounts. Long use, a weekly habit or a lingering sensation does not show how quickly C60 leaves a person's body. The original timing record also distinguishes animal measurements from human timing. NukeZA's long-term C60 account (Personal report · Accessed 2026-09-30)
One to two days and less than a day are forum extrapolations. Turnbuckle infers the first from a linked study of a different, dye-linked C70 fullerene, and guesses the second for activity within mitochondria from alcohol effects. Neither is a measured human C60-oil half-life; longer-retention theories remain disputed. Turnbuckle's C60 half-life speculation and linked C70 work (Secondhand community claim · Accessed 2026-09-30)
Baati's rat measurements are not human timing. After 4 mg/kg once, half-lives were 9.3 ± 2.7 hours orally and 13.9 ± 2.9 hours after abdominal injection (three rats per route). Separate repeated oral doses were approximately 1.7 mg/kg, with decreasing frequency. Small groups lived much longer in that study; this does not establish human life extension. Baati2012: rat C60 oil lifespan and kinetics (Animal context · Accessed 2026-09-30)
Source context — Hip's one-dose experience and a separate anonymous improvement story: Two distinct people: headline case is multi-step secondhand, not Hip's outcome. Baseline ME/CFS and spontaneous symptoms undermine causal attribution. No verified concentration for Hip's own dose. Supplier, recipe and shelf-life advice excluded; no inference that anonymous recovery proves efficacy.
Source context — Big_Un1t79's long-use C60 story: Retrospective report with unspecified C60 amount, unverified formulation and multiple habits. Persistent benefits not lifelong particle retention. Relative timestamp only; original publication date not inferred. No supporting illness/biomarker record inspected.
Source context — NukeZA's long-term C60 account: Same person as f63qxx, self-prepared oil, no assay or objective causal test. Weekly amount is not a specified per-administration or daily dose. Manufacturing recipe and supplier not reproduced. Good bloodwork is not comprehensive safety evidence.
Source context — Turnbuckle's C60 half-life speculation and linked C70 work: Forum speculation, different fullerene and endpoint, not measured human oral C60 kinetics. Linked primary URL redirected to blocked PMC2888797; indexed primary text identifies cultured human mast-cell work, but full primary body could not be opened this turn. No claim to have verified a numeric primary half-life, bodily distribution or stem-cell mechanism.
Source context — Baati2012: rat C60 oil lifespan and kinetics: Animal study with three rats per route for kinetics and six per lifespan group; not human timing, dosing or safety. Mirror is commercially hosted but contains the primary manuscript, not independent evidence. PDF screenshot failed; table text and route headings were inspected in extracted primary text. All PubMed/publisher/mirror prose counts as one Baati2012 source family.
Cycles people discuss
| Daily and weekly habits | Accounts include year-plus daily use, several years at a weekly total and four years followed by two years off. |
|---|---|
| Pulsed schedules | Weekly or every-other-week pulses appear in original talk, influenced by rat experiments. They do not establish a human loading phase, course or required break. |
Notes
Daily habits and weekly use both appear. Reports include year-plus daily use, several years at a weekly total and four years followed by two years off. These are personal histories, not a shared cycle or evidence that continuous use is necessary. C60 updates: a year-plus null report (Community discussion · Accessed 2026-09-30) · NukeZA's long-term C60 account (Personal report · Accessed 2026-09-30) · Big_Un1t79's long-use C60 story (Personal report · Accessed 2026-09-30)
Weekly and every-other-week pulses have animal-study influence. Those patterns and daily oil for months remain in the original discussion record. Copying a rat schedule does not establish a human course, loading phase, repeat interval or required break. C60 is not a short peptide course.
Source context — C60 updates: a year-plus null report: Null report is one self-prepared-oil user; no concentration assay or control. Repeated quoted copies of tintinet's post are not more users. Only inspected first page, not all108 replies.
Source context — NukeZA's long-term C60 account: Same person as f63qxx, self-prepared oil, no assay or objective causal test. Weekly amount is not a specified per-administration or daily dose. Manufacturing recipe and supplier not reproduced. Good bloodwork is not comprehensive safety evidence.
Source context — Big_Un1t79's long-use C60 story: Retrospective report with unspecified C60 amount, unverified formulation and multiple habits. Persistent benefits not lifelong particle retention. Relative timestamp only; original publication date not inferred. No supporting illness/biomarker record inspected.
Stacks
| Other longevity supplements | The original record discusses combinations with urolithin A, alpha-lipoic acid and polyphenol antioxidants, without a fixed ratio. C60 is not established as a rapamycin substitute. |
|---|
Notes
Other supplements: Urolithin A, alpha-lipoic acid and polyphenol antioxidants appear in longevity combinations without a fixed ratio. Their co-use makes attribution harder. [community]
Not a rapamycin substitute. [community]
Watch for
| Next-day adverse symptoms | Hip reports depression, fatigue and mild psychosis-like symptoms, then no retry. Similar symptoms also occurred without triggers; the timing does not prove C60 caused them. |
|---|---|
| Light and preparation | Mouse work found light-dependent toxicity and differences among commercial preparations. Dark storage does not establish human safety. |
| Oil and chronic unknowns | The record flags stomach tolerance, oil calories and possible solvent residues. Human chronic safety and interactions remain uncertain; oral-oil accounts do not establish safe injection. |
| Longevity disagreement | The famous rat lifespan result was not matched by a later mouse oral-oil study. Neither establishes longer human life. |
Notes
Next-day mood and fatigue symptoms were reported. Hip describes depression, greater fatigue and mild psychosis-like symptoms, then no redose. They also report these symptoms can occur without a trigger. The sequence warrants attention without proving C60 caused it; feeling worse is not evidence of beneficial detoxification. Hip's one-dose experience and a separate anonymous improvement story (Community discussion · Accessed 2026-09-30) · Big_Un1t79's long-use C60 story (Personal report · Accessed 2026-09-30)
Light exposure can change the preparation. Grohn's mouse work found light-dependent toxicity. Keeping oil dark does not establish human safety. The study also found differences among commercial preparations; a purity claim is not an assay of the bottle being discussed. Grohn: light-dependent toxicity and absent mouse lifespan benefit (Animal context · Accessed 2026-09-30)
Oil load and uncertain composition matter. The original record flags stomach tolerance, oil calories and possible solvent residues. Human chronic safety, pregnancy safety and interactions are uncertain. Oil reports do not establish safe injection. Other longevity agents complicate attribution; C60 is not a rapamycin substitute.
Baati's rat measurements are not human timing. After 4 mg/kg once, half-lives were 9.3 ± 2.7 hours orally and 13.9 ± 2.9 hours after abdominal injection (three rats per route). Separate repeated oral doses were approximately 1.7 mg/kg, with decreasing frequency. Small groups lived much longer in that study; this does not establish human life extension. Baati2012: rat C60 oil lifespan and kinetics (Animal context · Accessed 2026-09-30)
Grohn's mouse result differed. No significant oral C60-oil lifespan or healthspan benefit emerged against controls. Different animals and preparations limit comparison with Baati or humans. Grohn: light-dependent toxicity and absent mouse lifespan benefit (Animal context · Accessed 2026-09-30)
Source context — Hip's one-dose experience and a separate anonymous improvement story: Two distinct people: headline case is multi-step secondhand, not Hip's outcome. Baseline ME/CFS and spontaneous symptoms undermine causal attribution. No verified concentration for Hip's own dose. Supplier, recipe and shelf-life advice excluded; no inference that anonymous recovery proves efficacy.
Source context — Big_Un1t79's long-use C60 story: Retrospective report with unspecified C60 amount, unverified formulation and multiple habits. Persistent benefits not lifelong particle retention. Relative timestamp only; original publication date not inferred. No supporting illness/biomarker record inspected.
Source context — Grohn: light-dependent toxicity and absent mouse lifespan benefit: Publisher abstract reviewed, not current full methods. The indexed full-text lead describes IP light-toxicity testing; that route detail is not presented as freshly full-text verified. Do not turn a mouse preparation hazard into a measured human toxicity rate or dark-storage safety guarantee. Publisher, PubMed and PMC copies share one source allowance.
Source context — Baati2012: rat C60 oil lifespan and kinetics: Animal study with three rats per route for kinetics and six per lifespan group; not human timing, dosing or safety. Mirror is commercially hosted but contains the primary manuscript, not independent evidence. PDF screenshot failed; table text and route headings were inspected in extracted primary text. All PubMed/publisher/mirror prose counts as one Baati2012 source family.
Full notes
C60 is a molecule of 60 carbon atoms, discussed as an experimental oral oil for longevity and stamina. Reports include better cardio, no noticeable benefit and adverse symptoms. These do not establish slower aging.
What C60 oil actually is
- A carbon cage carried in oil. Buckminsterfullerene, fullerene and buckyballs are names used for C60. C60-OO means C60 in olive oil; the oil carries the molecule and contributes its own calories and properties. It is not a peptide or graphene. Community
- Different fullerene products are different experiments. Other vegetable-oil preparations appear in discussion. Topical fullerene cosmetics do not establish what swallowing C60 oil does. A bottle's color or concentration claim does not establish its composition. Community
What people hope to get from it
- Cardio, rather than a stimulant kick. NukeZA describes better cardio but explicitly rejects C60 as a nootropic or cure-all. Stamina and fatigue experiences differ between accounts. Reddit r/Nootropics
- Sleep, focus and general vitality are also claimed. A Biohackers contributor reports better sleep, vivid dreams, focus and energy. The account also includes exercise, fasting and other supplements, so it cannot isolate C60's contribution. Personal report
- Longevity remains a hope, not a felt result. NukeZA continues partly for possible longevity effects but says only time will tell. Years of use and better cardio do not measure lifespan. Personal report
Doses people report
- 5 mg per week in one long-term account. NukeZA reports oral C60 in olive oil since March 2015, mostly at that weekly total. It is not a stated 5 mg daily amount or a verified optimal dose. Personal report
- 3 mg on five days per week; separately, 7 mg daily. These are different users: stevesayshi's ME/CFS report and tintinet's year-plus account with no noticeable result. Keep their frequencies and outcomes separate. Personal report LongeCity
- 5 mL per use at a claimed 0.88 mg/mL. Demogirl06's training log initially describes this oral oil amount, equivalent to 4.4 mg if the concentration is correct. Later entries include 10 mL uses and skipped days; the reported concentration was not independently checked. Personal report
- A teaspoon or tablespoon is an oil volume. The original community record includes both spoon sizes and a commercial example of 25.6 mg per ounce. Concentration and ounce convention matter; spoon volumes cannot supply a universal C60 amount. Saturation and maintenance calculators are commercial claims, not established human requirements. Community
Half-life discussed in the community
- No measured human oral half-life in these accounts. Long use, a weekly habit or a lingering sensation does not show how quickly C60 leaves a person's body. The original timing record also distinguishes animal measurements from human timing. Personal report Community
- One to two days and less than a day are forum extrapolations. Turnbuckle infers the first from a linked study of a different, dye-linked C70 fullerene, and guesses the second for activity within mitochondria from alcohol effects. Neither is a measured human C60-oil half-life; longer-retention theories remain disputed. LongeCity
When people notice a change
- Immediate mild effects in one 1 mL account. Hip describes increased awareness, energy and calm after oral C60 oil, followed by an adverse next day. Phoenix Rising
- Days to weeks in a secondhand improvement story. The same thread relays another person's improvement after starting 1 mL daily, reported as 0.8 mg C60. That anonymous story is distinct from Hip's own one-dose experience and does not establish a usual onset. Phoenix Rising
How long reported effects last
- About two days for one reported symptom flare to clear. Hip describes post-exertional malaise, meaning a worsening of illness symptoms, despite little exertion. This is an adverse-event timeline, not a beneficial-effect window or proof of bodily clearance. Phoenix Rising
- A two-year persistence claim is retrospective. The Biohackers contributor says benefits continued two years after stopping. This does not prove lifelong C60 retention or a reproducible one-dose duration. Personal report
Courses and breaks people discuss
- Daily habits and weekly use both appear. Reports include year-plus daily use, several years at a weekly total and four years followed by two years off. These are personal histories, not a shared cycle or evidence that continuous use is necessary. LongeCity Personal report Personal report
- Weekly and every-other-week pulses have animal-study influence. Those patterns and daily oil for months remain in the original discussion record. Copying a rat schedule does not establish a human course, loading phase, repeat interval or required break. C60 is not a short peptide course. Community
Good to know
- Next-day mood and fatigue symptoms were reported. Hip describes depression, greater fatigue and mild psychosis-like symptoms, then no redose. They also report these symptoms can occur without a trigger. The sequence warrants attention without proving C60 caused it; feeling worse is not evidence of beneficial detoxification. Phoenix Rising Personal report
- Light exposure can change the preparation. Grohn's mouse work found light-dependent toxicity. Keeping oil dark does not establish human safety. The study also found differences among commercial preparations; a purity claim is not an assay of the bottle being discussed. Animal context
- Oil load and uncertain composition matter. The original record flags stomach tolerance, oil calories and possible solvent residues. Human chronic safety, pregnancy safety and interactions are uncertain. Oil reports do not establish safe injection. Other longevity agents complicate attribution; C60 is not a rapamycin substitute. Community Community
What the animal numbers refer to
- Baati's rat measurements are not human timing. After 4 mg/kg once, half-lives were 9.3 ± 2.7 hours orally and 13.9 ± 2.9 hours after abdominal injection (three rats per route). Separate repeated oral doses were approximately 1.7 mg/kg, with decreasing frequency. Small groups lived much longer in that study; this does not establish human life extension. Animal context
- Grohn's mouse result differed. No significant oral C60-oil lifespan or healthspan benefit emerged against controls. Different animals and preparations limit comparison with Baati or humans. Animal context
What actual experiences add
- More stamina can coexist with exhaustion. After two weeks, stevesayshi described longer physical and mental activity, less anxiety and more appetite. Follow-ups preserve baseline exhaustion and careful activity, not recovery. Personal report
- Long use can still feel like nothing. Beef_Newton reports no appreciable benefit across multiple products over long periods. Tintinet likewise reports nothing noticeable after more than a year. These counteraccounts matter alongside enthusiastic energy stories. Reddit r/Nootropics LongeCity
- Small changes did not convince one user of a cure-all. NukeZA mentions cardio, possible alcohol-tolerance changes and less irritating mosquito bites, while dismissing broad claims. Their favorable bloodwork and absence of noticed side effects do not establish safety. The two Reddit threads contain the same person's account, not independent confirmations. Reddit r/Nootropics Personal report
- A training log changes interpretation as it progresses. Demogirl06 initially questioned a boost and attributed shoulder improvement to warmth. Later entries describe less fatigue but also long sleep, tea or yerba mate and ongoing training; the shoulder remained injured. This is a mixed timeline, not proof of tissue repair. Personal report
- Strong stories include unsupported explanations. Big_Un1t79 reports no illness during the first two years of use. Their detox, lifetime-retention and antioxidant-strength explanations are not demonstrated reasons for the reported changes. Personal report
